About Index Trending news
Analyze
Top 50 Pricing
Merck

Merck

Merck

Merck's official Twitter handle. Intended for US residents only. Tweeting about our commitment to saving & improving lives.

Elsewhere

Alexa global traffic share

Twitter followers

Employees

Team size

10000+
Locations
HQ
Headquarters
Xconomy , New York Times Bits

Merck Surges As Bristol’s Immunotherapy Drug Stumbles in Lung Cancer

Health Earnings
Xconomy

Merck, Amgen Invest in Akili as Therapeutic Video Game Moves Ahead

Health Funding
Xconomy

Moderna Gets $200M More, Deepens Merck Ties With New Cancer Pact

Health Funding
The Motley Fool

Attention Merck Investors: It's Time to Start Worrying

Xconomy

Gerngross Mulls Buying Back GlycoFi After Merck Closes HQ

The Motley Fool

5 Surprising Comments in Merck's Quarterly Conference Call

The Motley Fool

Merck's Mixed Q1 Results Are Marred By 1 Disappointing Drug Debut

The Motley Fool

5 Data Points Wall Street Is Anxiously Awaiting in Merck's Q1 Report

Health Earnings
The Motley Fool

16 Reasons to Buy Merck and Never Sell

Health Stock markets
The Motley Fool

Patent Payoff? Merck's and Ionis Pharmaceuticals' Take Could Be Tiny

The Motley Fool

The Surprising Winner in Merck's Patent War With Gilead Sciences

Xconomy

Tech Megatransfer: Merck Pays Harvard $20M For "Accelerated" Cancer Drugs

The Motley Fool

Better Buy: Pfizer Inc. vs. Merck

Stock markets Earnings Health
The Motley Fool

Merck's Management Just Clued Investors in to These 3 Critical Points

Earnings Health Stock markets
GeekWire

Biotechnology company NanoString partners with Merck to create test for anti-cancer drug

Health Earnings
TechMoran

Merck accelerator to invest $45,000 into Kenyan digital healthcare startups

Funding Education
The Motley Fool

Curing Hepatitis C: How Gilead Sciences Plans to Beat Merck

Stock markets
The Motley Fool

2 Numbers in Merck's 4th-Quarter Report That Have Investors Worried

Earnings Health Stock markets
The Motley Fool

3 Numbers That Matter When Merck Reports Its Fourth-Quarter Results

Health Earnings Stock markets
The Motley Fool

Instant Analysis: Can Merck Make Waves In the Crowded Hepatitis C Space?